WASHINGTON (CN) - The Consumer Product Safety Commission plans to require child-resistant packaging for any product containing .08 milligrams of an imidazoline in a single package. A commonly known imidazoline is tetrahydrozoline, found in over-the-counter eye drops for bloodshot eyes.
Imidazolines constrict blood vessels, and are used for nasal congestion or eye irritation.
They also may start to shut down the heart or lungs in children treated with these drugs or who accidentally ingest them, according to the CPSC.
The CPSC has made a preliminary finding that when there are 0.08 milligrams or more of an imidazoline in a single package, it must have special packaging to protect children under 5 from serious personal injury or illness due to handling, using or ingesting it.
The CPSC seeks comments on its proposal. Written comments must be received by April 9.
Click the document icon for this regulation and others.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
Additional Reads
-
Alaska, Hawaiian Airlines April 17, 2024 -
-
Contributor-Test-Post-2024-04-12 April 12, 2024 -
